Stroke Research and Treatment最新文献

{"title":"Predicting Independence 6 and 18 Months after Ischemic Stroke Considering Differences in 12 Countries: A Secondary Analysis of the IST-3 Trial.","authors":"André Vieira,&nbsp;Patrícia Soares,&nbsp;Carla Nunes","doi":"10.1155/2021/5627868","DOIUrl":"https://doi.org/10.1155/2021/5627868","url":null,"abstract":"<p><strong>Objectives: </strong>This study is aimed at identifying the best clinical model to predict poststroke independence at 6 and 18 months, considering sociodemographic and clinical characteristics, and then identifying differences between countries.</p><p><strong>Methods: </strong>Data was retrieved from the International Stroke Trial 3 study. Nine clinical variables (age, gender, severity, rt-PA, living alone, atrial fibrillation, history of transient ischemic attack/stroke, and abilities to lift arms and walk) were measured immediately after the stroke and considered to predict independence at 6 and 18 months poststroke. Independence was measured using the Oxford Handicap Scale. The adequacy, predictive capacity, and discriminative capacity of the models were checked. Countries were added to the final models.</p><p><strong>Results: </strong>At 6 months poststroke, 35.8% (<i>n</i> = 1088) of participants were independent, and at 18 months, this proportion decreased to 29.9% (<i>n</i> = 747). Both 6 and 18 months poststroke predictive models obtained fair discriminatory capacities. Gender, living alone, and rt-PA only reached predictive significance at 18 months. Poststroke patients from Poland and Sweden showed greater chances to achieve independence at 6 months compared to the UK. Poland also achieved greater chances at 18 months. Italy had worse chances than the UK at both follow-ups. <i>Discussion</i>. Six and eight variables predicted poststroke independence at 6 and 18 months, respectively. Some variables only reached significance at 18 months, suggesting a late influence in stroke patients' rehabilitation. Differences found between countries in achieving independence may be related to healthcare system organization or cultural characteristics, a hypothesis that must be addressed in future studies. These results can allow the development of tailored interventions to improve the outcomes.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39306472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Presentation, Treatment, and Outcomes.","authors":"Timothy G White,&nbsp;Gabriela Martinez,&nbsp;Jason Wang,&nbsp;Michele Gribko,&nbsp;Artem Boltyenkov,&nbsp;Rohan Arora,&nbsp;Jeffrey M Katz,&nbsp;Henry H Woo,&nbsp;Pina C Sanelli","doi":"10.1155/2021/8653396","DOIUrl":"https://doi.org/10.1155/2021/8653396","url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization declared COVID-19 a global pandemic last year. While a clear impact of COVID-19 on the declining stroke volume has been reported, its overall impact on stroke presentation and clinical outcomes has not been established. The purpose of this study was to assess the impact of COVID-19 on acute ischemic stroke volume, presentation, treatment, and outcomes at comprehensive stroke centers.</p><p><strong>Methods: </strong>A retrospective review of patients with a discharge diagnosis of acute ischemic stroke from the Get With The Guidelines database was performed from January 1, 2019, to July 1, 2020. The following time periods were defined: Pre-COVID (January/February), Peak-COVID (March/April), and Post-COVID (May/June). Bivariate analyses were performed comparing the 2020 and 2019 time periods to determine differences in stroke volume, presentation, treatment, and outcomes.</p><p><strong>Results: </strong>Stroke volumes were significantly lower during the Peak-COVID period in 2020 compared to that in 2019, with an absolute decline of 49.5% (<i>P</i> < 0.001). Patients were more likely to present after 24 hours from last known well during the 2020 Peak-COVID period (<i>P</i> = 0.03). However, there was not a significant difference in the rate of treatment with either the tissue plasminogen activator (tPA) or mechanical thrombectomy during the Peak-COVID period. Interestingly, relative treatment rates increased during the 2020 Post-COVID period to 11.4% (<i>P</i> = 0.01).</p><p><strong>Conclusions: </strong>The overall ischemic stroke volume decreased during the pandemic, and patients had a tendency to present later, beyond eligible treatment windows. However, rates of treatment, patient demographics, and stroke outcomes did not significantly change when compared to the prior year.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39265829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Value of Perfusion CT in the Prediction of Intracerebral Hemorrhage after Endovascular Treatment.","authors":"Friederike Austein,&nbsp;Antonia Carlotta Fischer,&nbsp;Jens Fiehler,&nbsp;Olav Jansen,&nbsp;Thomas Lindner,&nbsp;Susanne Gellißen","doi":"10.1155/2021/9933015","DOIUrl":"https://doi.org/10.1155/2021/9933015","url":null,"abstract":"<p><strong>Background: </strong>Intracerebral hemorrhage (ICH) is a serious complication of endovascular treatment (EVT) in stroke patients with large vessel occlusion (LVO) and associated with increased morbidity and mortality.</p><p><strong>Aims: </strong>Identification of radiological predictors is highly relevant. We investigated the predictive power of computed tomography perfusion (CTP) parameters concerning ICH in patients receiving EVT.</p><p><strong>Methods: </strong>392 patients with anterior circulation LVO with multimodal CT imaging who underwent EVT were analyzed. CTP parameters were visually evaluated for modified ASPECTS regions and compared between patients without ICH, those with hemorrhagic infarction (HI), and those with parenchymal hematoma (PH) according to the ECASS criteria at follow-up imaging and broken down by ASPECTS regions.</p><p><strong>Results: </strong>168 received intravenous thrombolysis (IV-rtPA), and 115 developed subsequent ICH (29.3%), of which 74 were classified as HI and 41 as PH. Patients with HI and PH had lower ASPECTS than patients without ICH and worse functional outcome after 90 days (<i>p</i> < 0.05). In 102 of the 115 patients with ICH, the deep middle cerebral artery (MCA) territory was affected with differences between patients without ICH, those with HI, and those with PH regarding cerebral blood volume (CBV) and blood-brain barrier permeability measured as flow extraction product (FED) relative to the contralateral hemisphere (<i>p</i> < 0.05). Patients with PH showed larger perfusion CT infarct core than patients without ICH (<i>p</i> < 0.01).</p><p><strong>Conclusion: </strong>None of the examined CTP parameters was found to be a strong predictor of subsequent ICH. ASPECTS and initial CTP core volume were more reliable and may be useful and even so more practicable to assess the risk of subsequent ICH after EVT.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39265830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Pharyngeal Electrical Stimulation on Swallow Timings, Clearance and Safety in Post-Stroke Dysphagia: Analysis from the Swallowing Treatment Using Electrical Pharyngeal Stimulation (STEPS) Trial.","authors":"Lisa F Everton,&nbsp;Jacqueline K Benfield,&nbsp;Emilia Michou,&nbsp;Shaheen Hamdy,&nbsp;Philip M Bath","doi":"10.1155/2021/5520657","DOIUrl":"https://doi.org/10.1155/2021/5520657","url":null,"abstract":"<p><p>Swallowing impairment (dysphagia) post-stroke results in poorer outcomes. Pharyngeal electrical stimulation (PES) is a potential treatment for post-stroke dysphagia. In a post hoc analysis, we investigated PES using videofluoroscopy swallow studies (VFSS) from the STEPS trial incorporating multiple measures of safety (penetration aspiration scale-PAS), speed and duration (timing), and efficiency (clearance), as opposed to the original trial which only measured PAS scores. 81 randomised participants (PES (<i>N</i> = 43) versus sham (<i>N</i> = 38)) were analysed at baseline and 2 weeks. Participants swallowed up to 6 × 5 ml and 1 × 50 ml of thin liquid barium at 40% <i>w</i>/<i>v</i>, images at ≥25 fps. Based on PAS, the 5 ml mode bolus (most frequently occurring PAS from 6 × 5 ml) and the worst 50 ml bolus were chosen for further analysis. Eight timing measures were performed, including stage transition duration (STD) and pharyngeal transit time (PTT). Clearance measures comprised oral and pharyngeal residue and swallows to clear. Comparisons of change of scoring outcomes between PES and sham were done at 2 weeks. Wilcoxon Signed Ranks Test was also used to evaluate longitudinal changes from both groups' combined results at two weeks. Between-group analysis showed no statistically significant differences. Issues with suboptimal image quality and frame rate acquisition affected final numbers. At two weeks, both groups demonstrated a significant improvement in most safety scores (PAS) and STD, possibly due to spontaneous recovery or a combination of spontaneous recovery and swallowing treatment and usual care. A nonsignificant trend for improvement was seen in other timing measures, including PTT. This study, which conducted additional measurements of kinematic and residue analysis on the STEPS data did not detect \"missed\" improvements in swallowing function that the PAS is not designed to measure. However, more studies with greater numbers are required.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39073701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Sociodemographic Factors, Concomitant Disease States, and Measures Performed in the Emergency Department on Patient Disability in Ischemic Stroke: Retrospective Study from Lebanon.","authors":"Diana Malaeb,&nbsp;Souheil Hallit,&nbsp;Hiba Al Harfany,&nbsp;Sara Mansour,&nbsp;Frederic Faugeras,&nbsp;Pascale Salameh,&nbsp;Hassan Hosseini","doi":"10.1155/2021/5551558","DOIUrl":"https://doi.org/10.1155/2021/5551558","url":null,"abstract":"<p><strong>Background: </strong>Stroke is a leading cause of death and disability in developed countries. The major factor affecting long-term survival other than age is the disability severity caused by stroke. The modified Rankin Scale (mRS) is a global functional endpoint measurement used in acute stroke to evaluate the degree of disability or dependence in daily life activities. The objective of this study was to assess the effects of sociodemographic factors, concomitant disease states, and some measures performed in the emergency department (ED) on patients' disability.</p><p><strong>Methods: </strong>We conducted a retrospective study on ischemic stroke patients admitted to Intensive Care Unit of three Lebanese university hospitals between June and December 2016. Patients were excluded if they had been discharged from ED without hospital admission or if mRS was not performed. The mRS was further subdivided into two categories considered as \"good prognosis\" (0-2 or 0-3) and \"poor prognosis\" (>2 or > 3).</p><p><strong>Results: </strong>204 patients were included in the study with mean age of 65.4 ± 11.9 years, hypertension was the most previous concomitant past medical disease (77.1%), and 27.1% of these patients had previous history of stroke. No significant differences were found in both mRS categories for all sociodemographic factors, and past medical history except that arrhythmia was significantly more common in the higher mRS categories > 2 and > 3. Based on multivariable analysis, there was a trend for previous intake of calcium channel blocker to be associated with lower mRS at admission (beta -0.586). However, intracranial arterial stenosis, ED blood glucose > 180 mg/dL, and performing brain imaging above 20 minutes after patient presentation to ED were significantly associated with higher mRS scores at discharge with an ORa and (confidence interval) of 2.986 (0.814, 10.962), 3.301 (1.072, 1.261), and 1.138 (1.071, 9.080), respectively.</p><p><strong>Conclusion: </strong>mRS is affected by previous disease states, prescribed medications, and acute measures performed in ED. It is also influenced by intracranial arterial stenosis etiology, which is associated with worse outcome.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39240225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia.","authors":"Alejandro Roman-Gonzalez,&nbsp;Carlos Andrés Naranjo,&nbsp;Walter D Cardona-Maya,&nbsp;Dionis Vallejo,&nbsp;Francisco Garcia,&nbsp;Cesar Franco,&nbsp;Leonor Alvarez,&nbsp;Luis Ignacio Tobón,&nbsp;Marta Ibeth López,&nbsp;Carolina Rua,&nbsp;Gabriel Bedoya,&nbsp;Ángela Cadavid,&nbsp;José Domingo Torres","doi":"10.1155/2021/9924710","DOIUrl":"https://doi.org/10.1155/2021/9924710","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention.</p><p><strong>Materials and methods: </strong>Three hundred fifty patients presenting ischemic strokes and 100 healthy controls under aspirin treatment were evaluated using the optic platelet aggregation test.</p><p><strong>Results: </strong>Aspirin resistance was found in 7.4% of the patients with ischemic stroke and 4% of controls. Aspirin resistance was associated with stroke recurrence in univariate analysis (<i>p</i> = 0.004). Aspirin resistance was not associated with smoking, diabetes, or hypercholesterolemia.</p><p><strong>Conclusion: </strong>Aspirin resistance is present in Colombian patients with ischemic stroke as well as in healthy controls.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39066165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sex, Knowledge, and Attitude of Stroke Survivors Attending Bebe Herbal Center on Risk Factors before and after Stroke.","authors":"Polycarp U Nwoha,&nbsp;Florence O Okoro,&nbsp;Emmanuel C Nwoha,&nbsp;Fidelia N Chukwu,&nbsp;Chidinma O Nwoha,&nbsp;Nkeiru C Ogoko,&nbsp;Peace N Nwoha,&nbsp;Chika A Idaguko,&nbsp;Augustine U Obi,&nbsp;Ezenna M Agwu,&nbsp;Iyanu O Ayoola,&nbsp;Sunday O Osonwa,&nbsp;Ifeoma H Okpara","doi":"10.1155/2021/6695522","DOIUrl":"https://doi.org/10.1155/2021/6695522","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to investigate the extent stroke survivors who attended an herbal center knew of stroke risk factors and whether significant sex differences existed. <i>Study Design</i>. This was a cross-sectional study conducted from January to June 2018 at Bebe Herbal Center, and it involved two well-trained assistants who interviewed 149 first-time stroke survivors after consent and ethical approval were obtained. The survivors self-reported their knowledge, attitude, and beliefs on risk factors before and after stroke. <i>Statistical Analyses</i>. Means of continuous variables were compared using Student's unpaired <i>t</i>-test, while categorical variables between males and the females were analyzed using Pearson's chi-square test. <i>P</i> < 0.05 was taken as significant.</p><p><strong>Results: </strong>Mean age of men (64.81 ± 1.24 yrs) was significantly higher than that of women (61.39 ± 1.42 yrs) (<i>F</i> = 0.096, <i>t</i> = 1.79, df = 147; <i>P</i> < 0.05). More men than women were 60 years and above while more women than men were below 60 years. Pearson's chi-square test showed significant association of sex with education (<i>χ</i> ² = 12.31; df = 3, <i>P</i> < 0.006), occupation (<i>χ</i> ² = 23.65; df = 4, <i>P</i> < 0.001), alcohol intake (<i>χ</i> ² = 24.23; df = 1; <i>P</i> < 0.001), and smoking (<i>χ</i> ² = 9.823; df = 1; <i>P</i> < 0.001). The commonest risk factor suffered was hypertension (73.1%), followed by alcohol intake (59.1%), smoking (31.5%), and diabetes mellitus (26.7%); these affected men more than women. Male survivors unaware of their hypertensive status were more likely to have stroke than females, and age had a significant effect on the likelihood of developing a stroke; the same was occupation.</p><p><strong>Conclusions: </strong>These survivors suffered mainly from hypertension, triggered by psychosocial problems and diabetes mellitus; their stroke seemed fueled by unrecognized hypertension, unrecognized diabetes mellitus, ignorance of hyperlipidemia, and wide-scale belief in witchcraft as risk factor. Awareness programs in the third world should take these observations into consideration.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38996448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility of a Self-Managed, Video-Guided Exercise Program for Community-Dwelling People with Stroke.","authors":"Katharine Scrivener,&nbsp;Jessica Sewastenko,&nbsp;Alexandra Bouvier-Farrell,&nbsp;Katherine MacDonald,&nbsp;Tegan Van Rijn,&nbsp;Joshua Tezak,&nbsp;Nicholas Mandis,&nbsp;Sherrie Love","doi":"10.1155/2021/5598100","DOIUrl":"https://doi.org/10.1155/2021/5598100","url":null,"abstract":"<p><strong>Background: </strong>Ongoing rehabilitation after stroke is limited. Using video-guided exercises, which are implemented with a self-management approach, may be a way to facilitate ongoing exercise in the home environment.</p><p><strong>Objectives: </strong>To investigate the feasibility of a video-guided exercise program, implemented with a self-management approach for people with stroke.</p><p><strong>Methods: </strong>A phase I, single-group, clinical trial. The study comprised two phases: in phase one, four weeks of the program was supported by weekly supervised sessions and in phase two, four weeks of the program was completed without direct supervision. Demographic information was recorded at baseline. Adherence and adverse events were self-reported via a logbook. Acceptability was measured through a purpose-built scale. Physical performance, physical activity, and exercise self-efficacy were measured at baseline and 4 and 8 weeks.</p><p><strong>Results: </strong>Sixteen people with stroke were recruited; however, 14 commenced and completed the study. Adherence during the supervised phase was 3.3 hours per week and 2.3 hours per week during the self-directed phase. There were no adverse events. Most participants indicated that the program was easy to use (92%) and would recommend the program to others (86%). Walking speed improved over the duration of the program (mean difference -0.12 m/s, 95% CI -0.22 to -0.02, <i>p</i> = 0.02). Self-efficacy and physical activity did not change over the duration of the program.</p><p><strong>Conclusion: </strong>The findings support the feasibility of a video-guided exercise program for people with stroke. Further research to confirm the effectiveness of this intervention to improve physical function is warranted.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39018149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treadmill Exercise during Pregnancy Decreased Vulnerability to Neonatal Hypoxia-Ischemia through Reducing Inflammation and Increasing Antiapoptotic Gene Expressions and Antioxidant Capacity in Rats.","authors":"Elahe Gorgij,&nbsp;Hamed Fanaei,&nbsp;Parichehr Yaghmaei,&nbsp;Mohammad Reza Shahraki,&nbsp;Hadi Mirahmadi","doi":"10.1155/2021/5512745","DOIUrl":"https://doi.org/10.1155/2021/5512745","url":null,"abstract":"<p><strong>Background: </strong>The purpose of present study was to assess the impact of maternal treadmill exercise during pregnancy on inflammation, oxidative stress, expression of Bax and Bcl-2 genes, and brain-derived neurotrophic factor (BDNF) level in neonatal rat brain after the hypoxia-ischemia injury. <i>Material and Methods</i>. A total of 24 female Wistar rats were utilized in this research. Two groups are randomly considered for rats: (1) not exercised through pregnancy and (2) exercised during pregnancy. Offsprings were divided into four groups including after delivery: (1) sham, (2) sham/exercise (sham/EX), (3) HI, and (4) HI+exercise. HI was induced in pups at postnatal day 8. Neurobehavioral tests were done seven days after HI induction. Then, the brain tissue was taken from the skull to estimate Bcl-2 and Bax gene expressions, BDNF, cerebral edema, infarct volume, inflammatory factors, oxidative stress, and neurological function.</p><p><strong>Results: </strong>The BDNF level in the HI+exercise group was considerably higher than the HI, sham, and sham/EX groups. Tumor necrosis factor (TNF-<i>α</i>), C-reactive protein (CRP), and the whole oxidant capacity (TOC) levels in the HI group were significantly higher than the sham and sham/EX groups. TNF-<i>α</i>, CRP, and TOC levels in the HI+exercise group were significantly lower than the HI group. Total antioxidant capacity (TAC) level in the HI+exercise group was significantly higher than the HI group. Infarct volume and edema percent in the HI+exercise group were significantly lower than the HI group. Neurological function in the HI+exercise group was significantly better than the HI group. Bax expression in the HI+exercise group was significantly lower than the HI group. Bcl-2 expression in the HI+exercise group was significantly higher than the HI group. In the sham group, BDNF, TNF-<i>α</i>, CRP, TAC, TOC, edema levels, and neurological function had no significant difference with the sham/EX group.</p><p><strong>Conclusion: </strong>It appears that the maternal treadmill exercise during pregnancy exerts a supportive impact against neonatal HI brain injury through increasing antioxidant capacity, Bcl-2 expression, and BDNF levels and decreasing inflammation that is resulted in the lower infarct volume and sensorimotor dysfunction.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38950448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial.","authors":"Rizaldy Taslim Pinzon,&nbsp;Raymond R Tjandrawinata,&nbsp;Vincent Ongko Wijaya,&nbsp;Vanessa Veronica","doi":"10.1155/2021/5541616","DOIUrl":"https://doi.org/10.1155/2021/5541616","url":null,"abstract":"<p><strong>Background: </strong>There are still some unmet needs for stroke management and safety. DLBS1033 is a protein fraction extracted from the earthworm <i>Lumbricus rubellus</i> that has shown fibrinolytic and fibrinogenolytic activities, reduces blood viscosity, and inhibits platelet aggregation that it can be considered an add-on therapy and potential medical breakthrough in acute ischemic stroke management.</p><p><strong>Objective: </strong>This study is aimed at measuring the benefit of DLBS1033 in acute ischemic stroke management.</p><p><strong>Methods: </strong>This was a randomized, open-label trial at a referral stroke center from November 2019 to December 2020. Subjects who met the inclusion criteria were randomly divided into a control group and an experimental group. The control group received standard therapy consisting of aspirin 100 mg once daily, atorvastatin 20 mg once daily, and vitamin B₁₂ 100 mg three times daily. The experimental group received standard therapy and DLBS1033 three times daily. The functional outcomes were measured using the National Institutes of Health Stroke Scale (NIHSS), Barthel Index (BI), and modified Rankin Scale (mRS) at baseline, hospital discharge, and day 30.</p><p><strong>Results: </strong>Collected data from 180 subjects was analyzed. The NIHSS scores' improvements were significantly greater in the experimental group compared to the control group at both hospital discharge (-5.57 ± 2.16 vs. -3.64 ± 2.65; <i>p</i> < 0.001) and day 30 (-6.62 ± 2.64 vs. -5.14 ± 2.41; <i>p</i> = 0.001). Compared with the control group, the improvements in the BI scores were significantly better in the experimental group, at both hospital discharge (10.69 ± 5.36 vs. 6.64 ± 5.04; <i>p</i> < 0.001) and day 30 (10.9 ± 8.19 vs. 8.56 ± 7.45; <i>p</i> = 0.003). The distribution of mRS scores was improved in both groups during 30 days of follow-up and was more favorable in the experimental group. In both groups, a favorable outcome (mRS < 2) was achieved better at day 30 (86.7% vs. 80%; <i>p</i> = 0.302) than at baseline (0% vs. 6.7%; <i>p</i> = 0.028) and at hospital discharge (58.9% vs. 43.3%; <i>p</i> = 0.085). There was no clinically significant adverse event related to the study product.</p><p><strong>Conclusions: </strong>DLBS1033 in addition to the standard care was more effective in improving functional status compared to standard care alone in acute ischemic stroke patients with a similar safety profile.</p>","PeriodicalId":22054,"journal":{"name":"Stroke Research and Treatment","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049819/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38933557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}